These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 8624686)
1. Central activation of the trigeminovascular pathway in the cat is inhibited by dihydroergotamine. A c-Fos and electrophysiological study. Hoskin KL; Kaube H; Goadsby PJ Brain; 1996 Feb; 119 ( Pt 1)():249-56. PubMed ID: 8624686 [TBL] [Abstract][Full Text] [Related]
2. Comparison of more and less lipophilic serotonin (5HT1B/1D) agonists in a model of trigeminovascular nociception in cat. Hoskin KL; Goadsby PJ Exp Neurol; 1998 Mar; 150(1):45-51. PubMed ID: 9514827 [TBL] [Abstract][Full Text] [Related]
3. Substance P blockade with the potent and centrally acting antagonist GR205171 does not effect central trigeminal activity with superior sagittal sinus stimulation. Goadsby PJ; Hoskin KL; Knight YE Neuroscience; 1998 Sep; 86(1):337-43. PubMed ID: 9692766 [TBL] [Abstract][Full Text] [Related]
4. Fos expression in the trigeminocervical complex of the cat after stimulation of the superior sagittal sinus is reduced by L-NAME. Hoskin KL; Bulmer DC; Goadsby PJ Neurosci Lett; 1999 May; 266(3):173-6. PubMed ID: 10465701 [TBL] [Abstract][Full Text] [Related]
7. The NMDA receptor antagonist MK-801 reduces Fos-like immunoreactivity within the trigeminocervical complex following superior sagittal sinus stimulation in the cat. Classey JD; Knight YE; Goadsby PJ Brain Res; 2001 Jul; 907(1-2):117-24. PubMed ID: 11430892 [TBL] [Abstract][Full Text] [Related]
8. Differential effects of low dose CP122,288 and eletriptan on fos expression due to stimulation of the superior sagittal sinus in cat. Goadsby PJ; Hoskin KL Pain; 1999 Jul; 82(1):15-22. PubMed ID: 10422655 [TBL] [Abstract][Full Text] [Related]
9. Patterns of fos expression in the rostral medulla and caudal pons evoked by noxious craniovascular stimulation and periaqueductal gray stimulation in the cat. Knight YE; Classey JD; Lasalandra MP; Akerman S; Kowacs F; Hoskin KL; Goadsby PJ Brain Res; 2005 May; 1045(1-2):1-11. PubMed ID: 15910757 [TBL] [Abstract][Full Text] [Related]
10. Stimulation of the middle meningeal artery leads to Fos expression in the trigeminocervical nucleus: a comparative study of monkey and cat. Hoskin KL; Zagami AS; Goadsby PJ J Anat; 1999 May; 194 ( Pt 4)(Pt 4):579-88. PubMed ID: 10445825 [TBL] [Abstract][Full Text] [Related]
11. The spinal cord processing of input from the superior sagittal sinus: pathway and modulation by ergot alkaloids. Lambert GA; Lowy AJ; Boers PM; Angus-Leppan H; Zagami AS Brain Res; 1992 Dec; 597(2):321-30. PubMed ID: 1473003 [TBL] [Abstract][Full Text] [Related]
12. Blockade of calcitonin gene-related peptide release after superior sagittal sinus stimulation in cat: a comparison of avitriptan and CP122,288. Knight YE; Edvinsson L; Goadsby PJ Neuropeptides; 1999 Feb; 33(1):41-6. PubMed ID: 10657470 [TBL] [Abstract][Full Text] [Related]
13. The distribution of trigeminovascular afferents in the nonhuman primate brain Macaca nemestrina: a c-fos immunocytochemical study. Goadsby PJ; Hoskin KL J Anat; 1997 Apr; 190 ( Pt 3)(Pt 3):367-75. PubMed ID: 9147223 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of trigeminal neurons by intravenous administration of the serotonin (5HT)1B/D receptor agonist zolmitriptan (311C90): are brain stem sites therapeutic target in migraine? Goadsby PJ; Hoskin KL Pain; 1996 Oct; 67(2-3):355-9. PubMed ID: 8951929 [TBL] [Abstract][Full Text] [Related]
15. Serotonin inhibits trigeminal nucleus activity evoked by craniovascular stimulation through a 5HT1B/1D receptor: a central action in migraine? Goadsby PJ; Hoskin KL Ann Neurol; 1998 Jun; 43(6):711-8. PubMed ID: 9629840 [TBL] [Abstract][Full Text] [Related]
16. Evidence for 5-HT1B/1D receptors mediating the antimigraine effect of sumatriptan and dihydroergotamine. Buzzi MG; Moskowitz MA Cephalalgia; 1991 Sep; 11(4):165-8. PubMed ID: 1660351 [TBL] [Abstract][Full Text] [Related]
17. The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats. Goadsby PJ; Edvinsson L Ann Neurol; 1993 Jan; 33(1):48-56. PubMed ID: 8388188 [TBL] [Abstract][Full Text] [Related]
18. Differential trigeminovascular nociceptive responses in the thalamus in the familial hemiplegic migraine 1 knock-in mouse: a Fos protein study. Park J; Moon H; Akerman S; Holland PR; Lasalandra MP; Andreou AP; Ferrari MD; van den Maagdenberg AM; Goadsby PJ Neurobiol Dis; 2014 Apr; 64():1-7. PubMed ID: 24355314 [TBL] [Abstract][Full Text] [Related]
19. Expression of c-Fos-like immunoreactivity in the caudal medulla and upper cervical spinal cord following stimulation of the superior sagittal sinus in the cat. Kaube H; Keay KA; Hoskin KL; Bandler R; Goadsby PJ Brain Res; 1993 Nov; 629(1):95-102. PubMed ID: 8287282 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of trigeminal neurones after intravenous administration of naratriptan through an action at 5-hydroxy-tryptamine (5-HT(1B/1D)) receptors. Goadsby PJ; Knight Y Br J Pharmacol; 1997 Nov; 122(5):918-22. PubMed ID: 9384509 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]